Clinical Trials Logo

Superficial Thrombophlebitis clinical trials

View clinical trials related to Superficial Thrombophlebitis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01245998 Completed - Clinical trials for Superficial Thrombophlebitis

Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis

REVETR
Start date: December 1, 2010
Phase: Phase 4
Study type: Interventional

The aim of the study is to establish whether treatment of superficial vein thrombosis (SVT) with low-molecular-weight heparin in preventive or therapeutic doses prevents disease progression and thromboembolic events (deep vein thrombosis and pulmonary embolism), whether efficacy of low-molecular-weight heparin differs with regard to the dosage used (prevention, treatment), and to recognize groups of patients in which treatment with heparin is most efficient, as well as to determine factors that influence the efficacy of SVT treatment with heparin.

NCT ID: NCT00264381 Completed - Clinical trials for Superficial Thrombophlebitis

Management of Superficial Thrombophlebitis

Start date: October 2002
Phase: Phase 4
Study type: Interventional

The purpose of this study is to test the hypothesis that Fragmin (dalteparin sodium) subcutaneously once daily for 7 days is more effective than Ibuprofen given orally three times daily for 7 days for the treatment of superficial thrombophlebitis (STP).